Pacira BioSciences (PCRX) Shares Outstanding (Weighted Average) (2010 - 2026)

Pacira BioSciences' Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $40.5 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) fell 12.56% year-over-year to $40.5 million; the TTM figure through Mar 2026 stood at $40.5 million (down 12.56% YoY), while the FY2025 annual figure was $44.6 million, down 3.63% from the prior year.
• Shares Outstanding (Weighted Average) was $40.5 million for Q1 2026 at Pacira BioSciences, down from $44.6 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $46.5 million in Q1 2024 to a low of $40.5 million in Q1 2026.
• Historically, Shares Outstanding (Weighted Average) has averaged $45.4 million across 5 years, with a median of $45.9 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) grew 3.05% in 2022, then decreased 12.56% in 2026.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $45.5 million in 2022, then climbed by 1.54% to $46.2 million in 2023, then climbed by 0.05% to $46.2 million in 2024, then declined by 3.63% to $44.6 million in 2025, then fell by 9.21% to $40.5 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $40.5 million (Q1 2026), $44.6 million (Q4 2025), and $44.0 million (Q3 2025), per Business Quant data.